Annals of the American Thoracic Society

Scope & Guideline

Transforming respiratory medicine with timely and relevant contributions.

Introduction

Immerse yourself in the scholarly insights of Annals of the American Thoracic Society with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1546-3222
PublisherAMER THORACIC SOC
Support Open AccessNo
Country-
TypeJournal
Convergefrom 2004 to 2012, 2016 (coverage discontinued in Scopus)
AbbreviationANN AM THORAC SOC / Ann. Am. Thoracic Society
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address25 BROADWAY, 18 FL, NEW YORK, NY 10004

Aims and Scopes

The Annals of the American Thoracic Society focuses on advancing the understanding and treatment of respiratory diseases, critical care, and sleep medicine. This journal emphasizes high-quality research that contributes to the knowledge base of pulmonary and critical care medicine, aiming to improve patient care and outcomes.
  1. Pulmonary Diseases and Disorders:
    The journal covers a wide range of topics related to various pulmonary conditions, including asthma, chronic obstructive pulmonary disease (COPD), interstitial lung diseases, and pulmonary hypertension, with an emphasis on both clinical and translational research.
  2. Critical Care Medicine:
    Research in this area includes studies on managing critically ill patients, with a focus on respiratory failure, mechanical ventilation, and the impact of critical illness on long-term outcomes.
  3. Sleep Medicine:
    The journal publishes work on sleep-disordered breathing, including obstructive sleep apnea, its impact on overall health, and treatment strategies.
  4. Public Health and Environmental Impacts:
    Research addressing the intersections of respiratory health with public health issues, such as air pollution, smoking cessation, and health disparities, is a significant focus.
  5. Innovative Therapeutics:
    The journal highlights studies on novel therapeutic approaches, including biologics and pharmacological treatments for various pulmonary conditions.
  6. Multidisciplinary Approaches:
    Research that involves collaborative efforts across specialties, including insights from epidemiology, genetics, and health services research, is emphasized to address complex pulmonary issues.
The Annals of the American Thoracic Society has been adaptive in addressing contemporary issues in pulmonary and critical care medicine. Recent themes reflect emerging trends in research that respond to current health challenges and technological advancements.
  1. Impact of COVID-19 on Respiratory Health:
    A significant surge in studies related to the long-term effects of COVID-19 on pulmonary health, including post-COVID syndrome and its management, reflects the ongoing repercussions of the pandemic on respiratory care.
  2. Telemedicine and Remote Patient Monitoring:
    The rise of telehealth practices, particularly post-COVID-19, is leading to an increase in research on the effectiveness and implementation of telemedicine in managing chronic respiratory conditions.
  3. Health Disparities and Equity:
    There is an increasing focus on health equity, particularly regarding race, socioeconomic status, and access to care, as well as the impact of social determinants of health on pulmonary outcomes.
  4. Artificial Intelligence and Machine Learning Applications:
    Emerging research is increasingly utilizing AI and machine learning to improve diagnostics, treatment strategies, and predictive modeling in respiratory diseases.
  5. Environmental Health and Respiratory Disease:
    A growing body of literature examines the effects of environmental factors, including air pollution and climate change, on respiratory health, emphasizing the need for interdisciplinary approaches.
  6. Personalized Medicine in Pulmonary Care:
    There is a notable trend towards personalized approaches in treatment, particularly in asthma and COPD management, involving genetic, phenotypic, and biomarker-driven strategies.

Declining or Waning

While the journal has maintained a strong focus on various aspects of pulmonary and critical care medicine, certain themes have seen a decline in prominence over recent years, reflecting shifts in research priorities and emerging health challenges.
  1. Traditional Epidemiological Studies:
    There has been a noticeable decrease in the publication of traditional epidemiological studies that do not incorporate newer methodologies or technologies, such as big data analytics or machine learning, which are increasingly in demand.
  2. Basic Science Research:
    Although foundational research remains important, there appears to be a waning interest in purely laboratory-based studies without direct clinical implications, as the focus shifts towards translational research with immediate applications in patient care.
  3. Single-Disease Focus:
    Research that concentrates on single diseases in isolation is becoming less common, with a broader trend towards studies that consider comorbid conditions and the interconnectedness of various pulmonary disorders.
  4. Outdated Treatment Protocols:
    As new guidelines and treatment modalities emerge, older treatment protocols and their efficacy are being phased out, leading to fewer studies focused on traditional management strategies.
  5. Non-comprehensive Health Disparities Studies:
    Research focusing solely on health disparities without integrating social determinants of health or systemic factors has seen a decline, as the field moves towards more holistic approaches.

Similar Journals

CHEST

Connecting researchers and practitioners for impactful healthcare solutions.
Publisher: ELSEVIERISSN: 0012-3692Frequency: 12 issues/year

CHEST is a premier journal published by Elsevier, focusing on the vital fields of cardiology, critical care, and pulmonary medicine. Established in 1970, this esteemed journal has continually provided authoritative research, reviews, and clinical studies, catering to a global audience of healthcare professionals, researchers, and students. With an impressive impact factor, CHEST ranks in the top quartile (Q1) across its core categories according to the latest Scopus metrics, securing its position as a leading resource within cardiology (Rank #16), pulmonary (Rank #9), and critical care (Rank #8). Published quarterly, it offers a wealth of knowledge essential for advancing understanding and improving patient outcomes in these critical areas of healthcare. Researchers and practitioners are encouraged to submit their work, contributing to the ongoing discourse that shapes innovative practices and policies in respiratory and cardiovascular health.

Pulmonary Medicine

Unveiling Breakthroughs in Lung Health
Publisher: HINDAWI LTDISSN: 2090-1836Frequency: 1 issue/year

Pulmonary Medicine, published by HINDAWI LTD, stands as a prestigious open-access journal since 2010, dedicated to advancing the field of pulmonary and respiratory medicine. Located in Egypt, this journal is indexed with an ISSN of 2090-1836 and an E-ISSN of 2090-1844, and it has attained a commendable Q2 ranking in both the miscellaneous medicine and pulmonary health categories, indicative of its significant impact and quality. With an impressive Scopus ranking of #15 out of 155 in the pulmonary and respiratory medicine category, the journal is positioned in the 90th percentile, highlighting its relevance and contribution to ongoing research. The journal aims to publish high-quality original research, reviews, and clinical studies that address pressing issues in pulmonary health, making it a vital resource for researchers, clinicians, and students seeking to enhance their understanding and practice in respiratory medicine. By embracing an open-access model, Pulmonary Medicine provides a platform for disseminating knowledge, fostering collaboration, and driving innovation within the global scientific community.

Annals of Thoracic Medicine

Advancing knowledge in thoracic health.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1817-1737Frequency: 4 issues/year

Annals of Thoracic Medicine is a prominent open-access journal, published by Wolters Kluwer Medknow Publications, focusing on the critical fields of cardiology, pulmonary and respiratory medicine, and surgery. With an ISSN of 1817-1737 and an E-ISSN of 1998-3557, this journal aims to disseminate cutting-edge research, clinical findings, and innovative practices that can significantly impact the health outcomes of patients dealing with thoracic diseases. Since its inception in 2006, it has established itself as a reputable source of knowledge, achieving Q2 quartile rankings in 2023 across its main categories. Currently ranked #126 in Medicine & Surgery and exhibiting a growing SCOPUS percentile, the journal plays an essential role in advancing the understanding and treatment of thoracic conditions. Open access options ensure that research is readily available to a global audience, facilitating collaboration and knowledge sharing among researchers, healthcare professionals, and students in the field.

Lung India

Connecting researchers and clinicians for impactful findings.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0970-2113Frequency: 6 issues/year

Lung India is a premier open-access journal dedicated to the dissemination of high-quality research in the field of Pulmonary and Respiratory Medicine. Published by Wolters Kluwer Medknow Publications, it has been forging a path in respiratory healthcare since its inception in 2004. With its impactful contributions to clinical practice and research, Lung India holds a solid position in the academic landscape, evidenced by its ranking in the Q3 quartile for Pulmonary and Respiratory Medicine as of 2023, and its Scopus rank of #99 out of 155. The journal is particularly important for researchers, clinicians, and students in India and beyond, providing a platform for the latest findings and developments in respiratory care, lung disease management, and innovative treatment methods. With a commitment to accessibility, Lung India aims to promote knowledge sharing among professionals and support the advancement of respiratory health. The journal is well-equipped to cater to a diverse audience, ensuring that vital research is readily accessible and impactful.

Minerva Respiratory Medicine

Empowering professionals with vital respiratory knowledge.
Publisher: EDIZIONI MINERVA MEDICAISSN: 2784-8477Frequency: 4 issues/year

Minerva Respiratory Medicine is a prominent academic journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by EDIZIONI MINERVA MEDICA in Italy, this journal provides a vital platform for the dissemination of innovative research, clinical studies, and review articles that address the complexities of respiratory health. With an ISSN of 2784-8477 and an E-ISSN of 2724-6493, it serves as an open-access resource, allowing researchers, healthcare professionals, and students access to invaluable information without barriers. The journal is categorized in the fourth quartile of the 2023 rankings in the field of pulmonary and respiratory medicine, indicating its emerging role in the academic landscape. Despite its nascent status—converging from 2021 to 2024—Minerva Respiratory Medicine is committed to enhancing knowledge and practice in respiratory care, focusing on both innovative therapies and traditional approaches. With its aim to foster collaboration and communication among professionals in the field, this journal is an essential resource for those passionate about improving respiratory health outcomes.

BMC Pulmonary Medicine

Advancing respiratory health through open access research.
Publisher: BMCISSN: 1471-2466Frequency: 1 issue/year

BMC Pulmonary Medicine is a leading open access journal dedicated to the field of pulmonary and respiratory medicine, published by BMC since its inception in 2001. With an ISSN of 1471-2466, this journal plays a pivotal role in advancing knowledge and research dissemination in its field, maintaining a prominent position with a 2023 Scopus ranking of #65 out of 155 journals, placing it within the 58th percentile of the category. Based in the United Kingdom, it operates under a collaborative mission to provide unrestricted access to vital research, contributing to the global understanding of respiratory health issues. The journal is recognized for its commitment to high-quality, peer-reviewed research, as evidenced by its Q2 category designation in Pulmonary and Respiratory Medicine. BMC Pulmonary Medicine aims to foster innovation and scholarship among researchers, professionals, and students, making it an indispensable resource for anyone engaged in pulmonary research and practice. The journal, accessible to everyone, enables the dissemination of impactful research that can influence clinical practice and policy worldwide.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Leading the Charge in Respiratory Cell Research
Publisher: AMER THORACIC SOCISSN: 1044-1549Frequency: 12 issues/year

The AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, published by the esteemed American Thoracic Society, is a premier platform dedicated to advancing knowledge in the fields of pulmonary and respiratory medicine, cell biology, and clinical biochemistry. With an impressive impact factor and recognition as a Q1 journal in multiple categories for 2023, it ranks among the top tier of scholarly publications, evidencing its influence and contribution to the scientific community. Since its inception in 1989, the journal has provided a critical forum for researchers and professionals to disseminate innovative findings and pivotal reviews, driving forward the frontiers of respiratory biology. While the journal currently operates under traditional access mechanisms, it seeks to bridge gaps in research by presenting high-quality articles that address vital health challenges. As a key resource for both established researchers and emerging scholars in molecular biology and respiratory science, this journal plays a pivotal role in shaping the future of respiratory health advancements.

Pulmonology

Pioneering insights for a healthier tomorrow in pulmonology.
Publisher: ELSEVIERISSN: 2531-0437Frequency: 6 issues/year

Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.

Turkish Thoracic Journal

Exploring the forefront of thoracic research and clinical practice.
Publisher: AVESISSN: Frequency: 6 issues/year

Turkish Thoracic Journal, published by AVES, is a prominent open-access platform dedicated to advancing the field of pulmonary and respiratory medicine. Since its establishment, the journal has aimed to disseminate significant research findings, clinical studies, and reviews that contribute to an improved understanding of respiratory health challenges, with a particular focus on the Turkish context and regional issues. With an E-ISSN of 2149-2530 and transitioning to open access in 2022, the journal enhances visibility and accessibility, inviting a global audience of researchers, clinicians, and students to engage with the latest scientific work. The Turkish Thoracic Journal has been indexed in major databases, although it faced a coverage discontinuation in Scopus between 2016 and 2022. Currently positioned within the 23rd percentile among its peers in the field, it invites submissions that explore innovative approaches to thoracic health, enriching the discourse in a vital area of medicine.

RESPIRATORY RESEARCH

Advancing the Frontiers of Pulmonary Science
Publisher: BMCISSN: Frequency: 1 issue/year

RESPIRATORY RESEARCH is a leading open-access journal published by BMC, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2000, this journal has provided a vital platform for disseminating high-quality research, covering a broad spectrum of topics from basic science to innovative clinical practices in respiratory health. With an impressive impact factor and a Q1 ranking in the Pulmonary and Respiratory Medicine category, RESPIRATORY RESEARCH is recognized for its significant contribution to the literature, currently positioned at rank #19 out of 155 in the Scopus database, highlighting its relevance and influence within the medical community. The journal’s commitment to open access ensures that all articles are freely available to researchers, professionals, and students, fostering collaboration and knowledge sharing in the field. With its convergence years spanning from 2000 to 2024, RESPIRATORY RESEARCH remains at the forefront of respiratory medicine research, making it an essential resource for all stakeholders in this vital medical domain.